Skip to main content
. Author manuscript; available in PMC: 2024 Mar 14.
Published in final edited form as: Br J Sports Med. 2013 Oct 4;48(3):244–249. doi: 10.1136/bjsports-2013-092731

Table 2.

HRs for all-cause and cardiovascular disease mortality by levels of Leisure-time physical activity and muscle-strengthening activity among US adults who participated in the NHANES 1999–2004 during 4.8-year follow-up period

Deaths/number at risk* Mortality rate
Model 1
Model 2§
Model 3
Rate (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
All-cause mortality
Aerobic physical activity
 Inactive 436/4604 12.7 (11.3 to 14.1) 1.00 1.00 1.00
 Insufficiently active 99/2254 6.5 (4.9 to 8.2) 0.59 (0.45 to 0.77) 0.72** (0.54 to 0.97) 0.75** (0.54 to 1.05)
 Physically active 130/3677 4.9 (3.7 to 6.1) 0.47 (0.38 to 0.60) 0.64** (0.52 to 0.79) 0.70** (0.56 to 0.88)
Muscle-strengthening activity
 <2 times/week 605/8674 9.1 (8.2 to 10.0) 1.00 1.00 1.00
 ≥2 times/week 60/1861 5.4 (3.1 to 7.8) 0.68 (0.46 to 0.99) 0.87†† (0.56 to 1.36) 0.97†† (0.61 to 1.54)
CVD mortality
Aerobic physical activity
 Inactive 163/4604 4.4 (3.4 to 5.4) 1.00 1.00 1.00
 Insufficiently active 27/2254 1.6 (0.9 to 2.3) 0.45 (0.28 to 0.72) 0.57** (0.34 to 0.97) 0.53** (0.30 to 0.94)
 Physically active 43/3677 1.5 (1.0 to 2.1) 0.45 (0.28 to 0.73) 0.69** (0.43 to 1.12) 0.85** (0.50 to 1.43)
Muscle-strengthening activity
 <2 times/week 208/8674 2.9 (2.4 to 3.4) 1.00 1.00 1.00
 ≥2 times/week 25/1861 2.0 (1.1 to 2.8) 0.76 (0.49 to 1.18) 1.00†† (0.64 to 1.57) 1.17†† (0.67 to 2.04)
*

Unweighted numbers.

Age-adjusted, presented as per 1000 person-years.

Model 1: unadjusted.

§

Model 2: adjusted for sex, race/ethnicity, education, body weight status, smoking, heavy alcohol drinking, serum concentrations of total cholesterol and high-density lipoprotein cholesterol, elevated C reactive protein, eGFR, pre-existing chronic conditions (hypertension, diabetes mellitus, cardiovascular disease, asthma, arthritis, disability and cancer).

Model 3: subanalyses were conducted after excluding deaths that occurred during the first-year follow-up period while controlling for covariates as listed in model 2 (all deaths=577, CVD deaths=196).

**

With further adjustment for muscle-strengthening activity.

††

With further adjustment for aerobic physical activity.

CVD, cardiovascular disease.